Cannabinoid Amendments

Eliminated fingerprint background check requirements for cannabinoid processor license applicants, reducing administrative barriers for license holders.

Mandated video surveillance systems for industrial hemp retailers to monitor purchases and store records for at least 45 days.

Removed the requirement that certain cannabinoid products must be in a medicinal dosage form.

Added definitions for 'artificially derived cannabinoids' and expanded the list of prohibited substances in non-compliant material.

Changed background check eligibility criteria from drug-related felonies within 10 years to broader felony convictions.

Updated enforcement provisions to require cannabis processor licenses for transporting hemp concentrate.

Added detailed definitions for 'adulterant', 'artificially derived cannabinoid', 'cannabidiol', 'cannabidiolic acid', 'cannabis', 'delta-9-THC', 'industrial hemp', 'industrial hemp producer registration', 'industrial hemp product', 'industrial hemp retailer permit', and 'cannabinoid product class'.

Added specific THC level thresholds for cannabinoid products, including limits of 5 milligrams per serving and 150 milligrams per package.

Removed background check requirements for cannabinoid processor licenses that previously required submission of FBI criminal history records.

Added age requirement (must be at least 18 years old) and new criminal history submission requirements for cannabis processor license applicants.

Modified eligibility criteria for cannabis processor licenses by changing the drug-related misdemeanor disqualification period from ten years to within the previous ten years.

Added requirement for industrial hemp retailers to maintain video surveillance systems.

Added definitions for 'artificially derived cannabinoid' and specific prohibited cannabinoids like THCP and HHC to clarify what substances are banned in products.

Required industrial hemp retailers to maintain video surveillance systems for at least 45 days to monitor purchases.

Created a new independent medical cannabis pharmacy license with ownership restrictions preventing them from owning production facilities.

Repealed sections related to the state central patient portal, likely to be replaced by a new system.

Strengthened enforcement provisions including stricter background check requirements for license applicants.

Adjusted various effective dates and reporting deadlines for new licensing and surveillance requirements.

Added provisions for independent medical cannabis pharmacies with new license types and ownership restrictions

Changed background check requirements for cannabinoid processor licenses from mandatory fingerprinting to amended qualifications

Added video surveillance requirements for industrial hemp retailers with 45-day retention periods

Modified definitions to clarify artificially derived cannabinoids and THC analogs in both hemp and medical cannabis contexts

Adjusted enforcement provisions regarding seizure of non-compliant material and product testing procedures

Modified eligibility criteria for medical cannabis pharmacy licenses and expanded patient access provisions

Added numerous new code sections (4-41a-1006 and related sections) for medical cannabis pharmacy regulation

Maintained effective date of May 7, 2025 while adding new implementation timelines for pharmacy provisions

New definitions for 'artificially derived cannabinoid' and specific prohibited cannabinoids like THCP and HHC acetates that cannot be used in cannabinoid products.

Background check requirements for cannabinoid processor licenses now include fingerprint submissions to FBI databases and additional eligibility restrictions for individuals with recent drug-related felony convictions.

Industrial hemp retailers must maintain video surveillance systems capable of monitoring purchases, storing records for 45 days, and allowing department access upon request.

Transportation of hemp concentrate now requires a cannabinoid processor license or equivalent out-of-state license, with stricter enforcement provisions for underage sales.

Medical cannabis pharmacy provisions adjusted to allow additional pharmacy types, create independent pharmacy licenses with ownership restrictions, and modify fee structures.

Video surveillance requirements for hemp retailers begin on January 1, 2026, with the bill taking effect on May 7, 2025.

Various technical amendments to code sections including renumbering, conforming changes, and updates to Utah Code sections 4-41a-1001 through 4-41a-1206 related to medical cannabis operations.